Enavatuzumab Biosimilar - Anti-TNFRSF12A, CD266 mAb - Research Grade from ProteoGenix

Supplier Page

Supplier Page from
ProteoGenix for
Enavatuzumab Biosimilar - Anti-TNFRSF12A, CD266 mAb - Research Grade

Get Pricing
The Enavatuzumab Biosimilar - Anti-TNFRSF12A, CD266 mAb - Research Grade Antibody from ProteoGenix is a Human Monoclonal antibody.